Pharmacokinetics of susalimod, a highly biliary-excreted sulphasalazine analogue, in various species. Nonpredictable human clearance by allometric scaling

Pharmacy and Pharmacology Communications

Volumn 4, Issue 10, 1998, Pages 493-498

  Påhlman, Ingrid ^a,c   Edholm, Monica ^b   Kankaanranta, Sari ^a   Odell, Marie Louise ^a  

^a Dept of Drug Metabolism Research ^*  (Sweden)

^b PFIZER INC   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SALAZOSULFAPYRIDINE; SUSALIMOD; UNCLASSIFIED DRUG;

ADULT; ALLOMETRY; ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DOG; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXCRETION; FECES ANALYSIS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; RABBIT; RAT; SPECIES DIFFERENCE; SWINE;

EID: 18844481587     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J. Pharm. Biopharm. 10: 201-227
2. Davies, B., Morris, T. (1993) Physiological parameters in laboratory animals and humans. Pharm. Res. 10: 1093-1095
3. Ings, R. M. J. (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20: 1201-1231
4. Mahmood, I., Balian J. D. (1996) Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26: 887-895
5. Mordent, J. (1986) Man versus beast: pharmacokinetic scaling in mammals. J. Pharm. Sci. 75: 1028-1040
6. Neuman, V. C., Taggart, A. J., Le Gallez, P., Astbury, C., Hill, J., Bird, H. A. (1986) A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J. Rheumatol. 13: 285-287
7. Peppercorn, M. A. (1990) Advances in the drug therapy in inflammatory bowel disease. Ann. Intern. Med. 112: 50-60
8. Peppercorn, M. A., Goldman, P. (1972) The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J. Pharmacol. Exp. Ther. 181: 555-562
9. Preiss, R. (1998) P-Glycoprotein and related transporters. Int. J. Clin. Pharmacol. Ther. 36: 3-8
10. Pullar, T., Hunter, J. A., Capell, H. A. (1985) Which component of sulphasalazine is active in rheumatoid arthritis. Br. Med. J. 290: 1535-1538
11. Rains, C. P., Noble, S., Faulds, D. (1995) Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs 50: 137-156
12. Smith, R. L. (1971) Excretion of drugs in bile. In: Brodie, B. B., Gillette, J. (eds) Handbook of Experimental Pharmacology. Springer, New York, pp 355-389
13. Williams, K. M., Day, R. O., Breit, S. N. (1993) Biochemical actions and clinical pharmacology of anti-inflammatory drugs. Adv. Drug Res. 24: 123-198
14. Yamazaki, M., Suzuki, H., Sugiyama, Y. (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm. Res. 13: 497-513